Exceptional Response to Pembrolizumab and Trastuzumab in a Heavily Pretreated Patient With HER2-Positive TMB-H and MSI-H Metastatic Breast Cancer. (2021) - Li, Allen; Goodyear, Shaun; Fuss, Cristina; Mitri, Zahi